Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Siena

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
Archives Francaises De Pediatrie|February 1, 1983
[Disequilibrium of lymphocytic sub-groups in an child with familial lymphohistiocytosis]G Maggiore, M S Scotta, C De Giacomo, et al.
Haematologica|January 1, 1990
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF)S Siena, M Bregni, F Ravagnani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumorsM Moroni, S Veronese, R Schiavo, et al.
Biology of the Neonate|January 1, 1982
Colostral T lymphocytes detected by intracytoplasmic and membrane markersC Pignata, L Nespoli, R Maccario, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSFC Tarella, D Ferrero, M Bregni, et al.
Blood|May 15, 1992
Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrowA Orazi, G Cattoretti, R Schiró, et al.
Haematologica|January 1, 1989
Detection of occult leukemic cells in the autologous bone marrow graft of a patient with T-cell acute lymphoblastic leukemia by a highly specific and sensitive assayM Bregni, S Siena, M Subar, et al.
Haematologica|July 1, 1989
Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysisM Bregni, M G Borrello, S Siena, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1989
Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograftS Siena, M Bregni, A Formosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphomaA M Gianni, M Bregni, S Siena, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
Archives Francaises De Pediatrie|February 1, 1983
[Disequilibrium of lymphocytic sub-groups in an child with familial lymphohistiocytosis]G Maggiore, M S Scotta, C De Giacomo, et al.
Haematologica|January 1, 1990
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF)S Siena, M Bregni, F Ravagnani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumorsM Moroni, S Veronese, R Schiavo, et al.
Biology of the Neonate|January 1, 1982
Colostral T lymphocytes detected by intracytoplasmic and membrane markersC Pignata, L Nespoli, R Maccario, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSFC Tarella, D Ferrero, M Bregni, et al.
Blood|May 15, 1992
Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrowA Orazi, G Cattoretti, R Schiró, et al.
Haematologica|January 1, 1989
Detection of occult leukemic cells in the autologous bone marrow graft of a patient with T-cell acute lymphoblastic leukemia by a highly specific and sensitive assayM Bregni, S Siena, M Subar, et al.
Haematologica|July 1, 1989
Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysisM Bregni, M G Borrello, S Siena, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1989
Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograftS Siena, M Bregni, A Formosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphomaA M Gianni, M Bregni, S Siena, et al.
Pageof 17